Company: IMCR
Filing Date: 2025-02-26
Form Type: 8-K
Source: 0001140361-25-005988
Chunk: 0

Company: Immunocore Holdings plc
Filing Date: 2025-02-26
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02.      Results of Operations and Financial Condition.  

On February 26, 2025, Immunocore Holdings plc (the “ Company”) issued a press release announcing its financial results for the fourth
quarter and full year ended December 31, 2024, as well as other recent corporate updates. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.

The information in this Item 2.02 of this Current Report on 8-K, including Exhibits 99.1 hereto, is being furnished and shall not be
deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any of the
Company’s filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific
references in such filing.